Crystal Pharmatech provides customer focused solid-state services to help find and select the best form for early and late stage projects, as well as to characterize your API and formulation. We work with you and your manufacturing sites to provide an understanding of your solid form throughout the development process in order to produce API and drug product with consistent performance.
Solid-State Characterization Characterization of an API or drug product is critical to determine if a single form or multiple solid forms are present. A wide variety of solid-state techniques are available in our  >>	Solid Form Screening & Selection We tailor our screening and evaluation approach based on information from the client and our own experience with a wide range of compounds. >>	Single Crystal Growth and Structure Determination Growing crystals acceptable for single crystal x-ray diffraction (SCXRD) structure determination is challenging >>

Crystal Pharmatech is the first technology-driven, China based contract research organization (CRO) that focuses on materials science and engineering for drug development. We partner with clients to ensure comprehensive solutions for their needs in solid-state research, crystallization process development, and preformulation studies. We guide clients in the discovery and selection of the optimal solid phase for drug development using all aspects of pre-formulation studies, including API process and formulation development, regulatory support and intellectual property protection.

Founded in 2010, Crystal Pharmatech has business relationships with over 60 global pharmaceutical companies. High quality service, a culture of confidentiality, and fast turnaround with cost-effective pricing are our trademarks. As we continue to grow, Crystal Pharmatech will always keep customers our number one priority. We will also continue to be at the forefront of innovation in the field of solid-state chemistry so that our customers can reap the benefits of key discoveries in an ever changing field.

Our Scientific Advisory Board includes global leaders in drug development covering amorphous dispersions, co-crystals, crystallization, solid forms, formulation and pre-formulation. The role of our board is all encompassing while we search for new scientific areas for internal and external projects.